ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization
NCT02533778 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2017-08-02
Summary
A prospective pilot study to evaluate the recanalization and safety of mechanical thrombectomy through a cerebral angiogram in patients with stroke symptoms last seen normal between 8 - 24 hours.
Conditions
Interventions
- DEVICE
-
mechanical thrombectomy
Mechanical thrombectomy by either Penumbra system, TREVO, or Solitaire retrieval device
Sponsors & Collaborators
-
Abington Memorial Hospital
lead OTHER
Principal Investigators
-
Qaisar Shah, MD · Abington Memorial Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2018-07-01
- Completion
- 2018-07-01
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke
NCT05342038 ·Status: WITHDRAWN ·Phase: NA
-
Study of Aspirin and TPA in Acute Ischemic Stroke
NCT00417898 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
NCT05198323 ·Status: RECRUITING ·Phase: PHASE2
-
Argatroban Stroke Treatment - A Pilot Safety Study
NCT00268762 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke
NCT04818944 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
NCT02907736 ·Status: WITHDRAWN
-
Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization
NCT05395351 ·Status: COMPLETED
-
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538 ·Status: TERMINATED ·Phase: PHASE2
-
Mayo Acute Stroke Trial for Enhancing Recovery
NCT00805792 ·Status: COMPLETED ·Phase: PHASE2
-
Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage
NCT04891861 ·Status: UNKNOWN ·Phase: PHASE3
-
Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
NCT03519737 ·Status: UNKNOWN ·Phase: NA
-
Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke
NCT01778335 ·Status: TERMINATED ·Phase: PHASE3
-
Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting
NCT00585351 ·Status: COMPLETED ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA)
NCT01331200 ·Status: COMPLETED
-
Ultrasound for Acute Field Triage of Stroke
NCT05845203 ·Status: UNKNOWN ·Phase: NA
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Abciximab in Wake-up Stroke
NCT00167765 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK
NCT04752631 ·Status: COMPLETED ·Phase: PHASE4
-
Safe Implementation of Thrombolysis in Stroke - Monitoring Study
NCT02229812 ·Status: COMPLETED
-
A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)
NCT05295173 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
NCT01518231 ·Status: UNKNOWN ·Phase: PHASE1
-
Extending the Time for Thrombolysis in Emergency Neurological Deficits
NCT00887328 ·Status: COMPLETED ·Phase: PHASE3